JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol.105, no.12, 2020 (SCI-Expanded)
Context: Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder. Emerging animal and human data point to various changes in microbiota that could be linked with the syndrome. However, the effects of therapeutic approaches on gut microbial composition in women with PCOS remain unknown.